Chemokines and chemokine receptors in neurological disease: raise, retain, or reduce? (Q36963161)

17 August 2017

1 reference

title

Chemokines and chemokine receptors in neurological disease: raise, retain, or reduce? (English)

1 reference

17 August 2017

2

Richard M Ransohoff

1 reference

17 August 2017

Carine Savarin-Vuaillat

series ordinal

1

1 reference

17 August 2017

1 October 2007

1 reference

17 August 2017

1 reference

17 August 2017

4

1 reference

17 August 2017

590-601

1 reference

17 August 2017

4

1 reference

https://scigraph.springernature.com/pub.10.1016/j.nurt.2007.07.004

17 August 2017

0 references

cites work

Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.004

Structure and Functional Expression of a Human Interleukin-8 Receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.004

Chemokines: a new classification system and their role in immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.004

Chemokines--chemotactic cytokines that mediate inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.004

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.004

The MCP/eotaxin subfamily of CC chemokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.004

Lymphotactin: a cytokine that represents a new class of chemokine

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.004

A new class of membrane-bound chemokine with a CX3C motif

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.004

The many roles of chemokines and chemokine receptors in inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.004

Chemokine signaling and functional responses: the role of receptor dimerization and TK pathway activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.004

GRKs and arrestins: regulators of migration and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.004

The ins and outs of T-lymphocyte trafficking to the CNS: anatomical sites and molecular mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.004

Leukocyte extravasation: chemokine transport and presentation by the endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.004

Shear flow-dependent integration of apical and subendothelial chemokines in T-cell transmigration: implications for locomotion and the multistep paradigm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.004

Chemokines: immunology's high impact factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.004

Chemokines control fat accumulation and leptin secretion by cultured human adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.004

IL-18 enhances IFN-gamma-induced production of CXCL9, CXCL10, and CXCL11 in human keratinocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.004

The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.004

Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.004

A role for CXCR4 signaling in survival and migration of neural and oligodendrocyte precursors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.004

The chemokine receptor CXCR2 controls positioning of oligodendrocyte precursors in developing spinal cord by arresting their migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.004

Alterations in the oligodendrocyte lineage, myelin, and white matter in adult mice lacking the chemokine receptor CXCR2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.004

CXC chemokines interleukin-8 (IL-8) and growth-related gene product alpha (GROalpha) modulate Purkinje neuron activity in mouse cerebellum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.004

SDF-1alpha-mediated modulation of synaptic transmission in rat cerebellum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.004

Fractalkine/CX3CL1 depresses central synaptic transmission in mouse hippocampal slices.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.004

The expression and function of chemokines involved in CNS inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.004

Involvement of chemokine receptors in breast cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.004

Stromal cell-derived factor-1alpha promotes melanoma cell invasion across basement membranes involving stimulation of membrane-type 1 matrix metalloproteinase and Rho GTPase activities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.004

CXCL12-CXCR4 interactions modulate prostate cancer cell migration, metalloproteinase expression and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.004

CXCR4 expression mediates glioma cell invasiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.004

CXCR4 is a major chemokine receptor on glioma cells and mediates their survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.004

Application of the differential hybridization of Atlas Human expression arrays technique in the identification of differentially expressed genes in human glioblastoma multiforme tumor tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.004

Molecular characterization of CXCR-4: a potential brain tumor-associated gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.004

CXCL12 expression is predictive of a shorter time to tumor progression in low-grade glioma: a single-institution study in 50 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.004

Immunohistochemical study of the beta-chemokine receptors CCR3 and CCR5 and their ligands in normal and Alzheimer's disease brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.004

GROalpha/KC, a chemokine receptor CXCR2 ligand, can be a potent trigger for neuronal ERK1/2 and PI-3 kinase pathways and for tau hyperphosphorylation-a role in Alzheimer's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.004

Identification of monocyte chemoattractant protein-1 in senile plaques and reactive microglia of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.004

Chemokines and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.004

CCR1 is an early and specific marker of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.004

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.004

CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.004

Increased CXCL8 (IL-8) expression in Multiple Sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.004

CCR1+/CCR5+ mononuclear phagocytes accumulate in the central nervous system of patients with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.004

Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.004

Modulating CCR2 and CCL2 at the blood-brain barrier: relevance for multiple sclerosis pathogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.004

Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.004

Expression of chemokine receptors CCR1 and CCR5 reflects differential activation of mononuclear phagocytes in pattern II and pattern III multiple sclerosis lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.004

Association of CCR5 delta32 deletion with early death in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.004

CCR5Delta32 polymorphism effects on CCR5 expression, patterns of immunopathology and disease course in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.004

Identification and characterization of a potent, selective, and orally active antagonist of the CC chemokine receptor-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.004

Seeing is believing: in vivo evolution of multiple sclerosis pathology with magnetic resonance

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.004

Resistance to experimental autoimmune encephalomyelitis in mice lacking the CC chemokine receptor (CCR)2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.004

Discovery and pharmacological characterization of a novel rodent-active CCR2 antagonist, INCB3344.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.004

Treatment of experimental autoimmune encephalomyelitis with the chemokine receptor antagonist Met-RANTES.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.004

Severe disease, unaltered leukocyte migration, and reduced IFN-gamma production in CXCR3-/- mice with experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.004

A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.004

CXCL12 limits inflammation by localizing mononuclear infiltrates to the perivascular space during experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.004

Fractalkine modulates TNF-alpha secretion and neurotoxicity induced by microglial activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.004

Control of microglial neurotoxicity by the fractalkine receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.004

The neuronal chemokine CX3CL1/fractalkine selectively recruits NK cells that modify experimental autoimmune encephalomyelitis within the central nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.004

Chemokine blockers--therapeutics in the making?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.004

Blockade of chemokine signaling in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.004

Induction of experimental autoimmune encephalomyelitis in C57BL/6 mice deficient in either the chemokine macrophage inflammatory protein-1alpha or its CCR5 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.004

Novel mechanisms of the transendothelial migration of leukocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.004

Identification and localization of the cytokine SDF1 and its receptor, CXC chemokine receptor 4, to regions of necrosis and angiogenesis in human glioblastoma.

21 January 2018

1 reference

12 December 2020

Leukocyte recruitment during onset of experimental allergic encephalomyelitis is CCR1 dependent

1 reference

12 December 2020

Chemokines and chemokine receptors: their manifold roles in homeostasis and disease

1 reference

12 December 2020

Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer disease

1 reference

12 December 2020

Chemokine receptors in the central nervous system: role in brain inflammation and neurodegenerative diseases

1 reference

12 December 2020

Neurological disability correlates with spinal cord axonal loss and reduced N-acetyl aspartate in chronic multiple sclerosis patients

1 reference

12 December 2020

In-vivo imaging of Alzheimer disease beta-amyloid with [11C]SB-13 PET.

1 reference

12 December 2020

Investigating chemokines and chemokine receptors in patients with multiple sclerosis: opportunities and challenges

1 reference

12 December 2020

Chemokine receptor CXCR3 promotes colon cancer metastasis to lymph nodes

1 reference

12 December 2020

Immunolocalization of monocyte chemoattractant protein-1 in islets of NOD mice during cyclophosphamide administration

1 reference

12 December 2020

Role of high expression levels of CXCR4 in tumor growth, vascularization, and metastasis

1 reference

12 December 2020

Interleukin 8 expression regulates tumorigenicity and metastases in androgen-independent prostate cancer.

1 reference

12 December 2020

Point mutation causing constitutive signaling of CXCR2 leads to transforming activity similar to Kaposi's sarcoma herpesvirus-G protein-coupled receptor

1 reference

12 December 2020

Frequency of blood CX3CR1-positive natural killer cells correlates with disease activity in multiple sclerosis patients.

1 reference

12 December 2020

Multiple sclerosis and optic neuritis: CCR5 and CXCR3 expressing T cells are augmented in blood and cerebrospinal fluid

1 reference

12 December 2020

A putative chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen

1 reference

12 December 2020

A mutated CCR5 gene may have favorable prognostic implications in MS

1 reference

12 December 2020

Expression of interleukin-8 by human melanoma cells up-regulates MMP-2 activity and increases tumor growth and metastasis

1 reference

12 December 2020

Chemokines and their receptors in disease

1 reference

12 December 2020

Expression of the chemokine receptor CXCR3 on neurons and the elevated expression of its ligand IP-10 in reactive astrocytes: in vitro ERK1/2 activation and role in Alzheimer's disease

1 reference

12 December 2020

A novel mutant gene involved in T-lymphocyte-specific homing into peripheral lymphoid organs on mouse chromosome 4.

1 reference

12 December 2020

CCR5 Δ32, matrix metalloproteinase-9 and disease activity in multiple sclerosis

1 reference

12 December 2020

Structure-activity relationships of chemokines

1 reference

12 December 2020

CCR5 antagonists for the treatment of HIV.

1 reference

12 December 2020

beta-Amyloid stimulation of microglia and monocytes results in TNFalpha-dependent expression of inducible nitric oxide synthase and neuronal apoptosis.

1 reference

12 December 2020

10.1016/J.NURT.2007.07.004

Identifiers

DOI

1 reference

PubMed ID

17920540

Dimensions Publication ID

17 August 2017

0 references

1 reference

PubMed ID

17920540